According to Judge Chin, the "pharmaceutical representative's promotion of an FDA-approved drug's off-label use is speech" and he was prosecuted "precisely" because of his "speech in aid of pharmaceutical marketing.
Launching a new methodology called ‘Digital Dx’, for measuring, tracking and maximising healthcare firms’ brand influence across all digital channels, including web sites, social media, search engines and mobile
According to a ComScore’s June report on online browsing, the number of mobile internet users are predicted to surpass desktop users by 2014. And note, that’s by 2014, which means, during 2013, which means it’s all starting to look jolly soon.
Sanofi eyes diabetics with social mediaFierceBiotech ITSocial media platforms such as blogs, Facebook and Twitter offer Sanofi tools to learn perspectives from patients that employees of the pharma giant would not see otherwise, Dennis Urbaniak,...
PharmExecBlog summed up Cegedim's "2012 US Pharma Insights" survey this way: "while more pharma companies are using social media and mobile platforms to enhance their sales and marketing initiatives, budgets did ...
Pharma marketers are often urged to learn from other industries. Well, I have something that pharma marketers/communicators can learn from Dexter, "America's favorite serial killer." No, I'm not suggesting that marketers ...
“CEOs are embracing new models of working that tap into the collective intelligence of an organization and its networks to devise new ideas and solutions for increased profitability and growth,” said the statement released on Tuesday to the press.
This shift is seen in the CEOs’ preference to using social networks more than electronic mail or telephones as “primary communication vehicles.”
“Today only 16 percent of CEOs are using social-business platforms to connect with customers as individuals, but that number is poised to spike to 57 percent within the next three to five years.”
The trend of dropping e-mail and the phone as communications tools “is even more significant in Asean [Association of Southeast Asian Nations], where the use of social networks is expected to go up to 68 percent from the current 25 percent, as Asean CEOs plan a step-change from traditional to social media while continuing face-to-face engagement.”
“IBM’s research finds that technology is viewed as a powerful tool to recast organizational structures. More than half of CEOs [global: 53 percent, Asean: 53 percent] are planning to use technology to facilitate greater partnering and collaboration with outside organizations.”
Internally, too, digital communication tools are being eyed by more than half of CEOs (52 percent for global; 47 percent for Asean) to promote “great internal collaboration.”
IBM Philippines Country Manager for Global Business Services Jack Arambulo was quoted in the statement as saying that CEOs have realized “even greater levels of control are not the key to greater innovation and financial performance.”
'If patient engagement were a drug, it would be the blockbuster drug of the century and malpractice not to use it.
Let’s first take a look at the evidence, and then see where we can go from here.
First, the evidence for blockbuster drugs. In Dr. Eric Topol’s book “The Creative Destruction of Medicine,” he takes a deep look at the evidence for statins, possibly the biggest group of blockbuster drugs the last 20 years. Statins are a requirement of Meaningful Use Stage 1 clinical quality measures, as well as key measures for the CMS hospital quality measures used by many organizations, internal and external to the hospital, to grade the quality of care at a hospital. Prescribing statins, in many instances, is no longer optional. Topol states that “of every 100 patients taking Lipitor to prevent a heart attack one patient was helped, 99 were not.” These drugs cost $4 per day per patient and $1500 per year. While they are great at lowering cholesterol, it remains unclear that they do much to prevent heart attacks.
Now let’s take a look at a 2009 Kaiser study of coordinated cardiac care. Compared to those not enrolled in the study, coordinated care “patients have an 88 percent reduced risk of dying of a cardiac-related cause when enrolled within 90 days of a heart attack, compared to those not in the program.” And, “clinical care teams reduced overall mortality by 76 percent and cardiac mortality by 73 percent.”
“Recognizing the importance of early treatment and intervention, every patient who presented with CAD was enrolled in the program for both short- and long-term care.
“Physicians, nurses and pharmacists, using proven CAD risk-reduction strategies, work collaboratively with CAD patients to coordinate care. Activities such as lifestyle modification, medication management, patient education, laboratory results monitoring, and management of adverse events are all coordinated across a multifunctional team.”
Can you imagine what the headlines would be if a new cardiac drug showed this kind of effectiveness?'
Content is king, but in the mobile era, it will only remain king if it is optimized for mobile devices.
Bill Gates was the first to coin the phrase “content is king,” and ever since he coined it in 1996, content creators, website owners, journalists and pundits of the digital era have recited it, dissected it, argued about it or agreed on it.
A BMJ articled titled "Pharmaceutical research and development: what do we get for all that money?" was roundly criticized by Rich Meyer of World of DTC Marketing blog and Derek Lowe of In the Pipeline blog.